Etoposide (VP-16) in the treatment of lung cancer.

[1]  N. Nissen,et al.  Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[2]  J. Klastersky,et al.  Cisplatin, adriamycin, and etoposide (cav) for remission induction of small‐cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone‐marrow rescue , 1982, Cancer.

[3]  R. Wittes,et al.  Combination cis-platinum and etoposide in small-cell lung cancer. , 1982, Cancer treatment reviews.

[4]  F. Hirsch,et al.  Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis. , 1982, Cancer research.

[5]  U. Essers,et al.  Etoposide after ACO treatment for small-cell bronchogenic carcinoma. , 1982, Cancer treatment reviews.

[6]  D. Ettinger,et al.  Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP‐16 in small‐cell carcinoma of the lung , 1982, Cancer.

[7]  P. Creaven.  The clinical pharmacology of VM26 and VP16-213 , 1982, Cancer Chemotherapy and Pharmacology.

[8]  J. Ingle,et al.  Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers. , 1981, Cancer treatment reports.

[9]  C. Bloomfield,et al.  Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group B , 1980, Cancer.

[10]  R. Wittes,et al.  cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. , 1979, Cancer treatment reports.

[11]  D. Ettinger,et al.  Intensive induction therapy for small cell carcinoma of the lung. , 1979, Cancer treatment reports.

[12]  E. Soriano,et al.  VP 16‐213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M I , 1979 .

[13]  A. Ferguson,et al.  Chemotherapy of small cell carcinoma of the lung with V. P. 16–213 , 1978, Cancer.

[14]  J. Ingle,et al.  VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung. , 1978, Cancer treatment reports.

[15]  H. Senn,et al.  VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules. , 1978, Cancer treatment reports.

[16]  F. Hirsch,et al.  Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP‐16‐213 (NSC 141540, 4′‐demethylepipodophyllotoxin 9‐(4,6‐0‐ethylidene‐β‐D‐glucopyranoside) , 1977, Cancer.

[17]  J. Minna,et al.  Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. , 1977, Cancer treatment reports.

[18]  J. Rubin,et al.  VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer. , 1976, Cancer treatment reports.

[19]  N. Nissen,et al.  Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia. , 1976, European journal of cancer.

[20]  S. Marsoni,et al.  VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[21]  J. M. Gracia,et al.  Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL) , 2004, Cancer Chemotherapy and Pharmacology.

[22]  M. Méndez,et al.  Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy , 2004, Cancer Chemotherapy and Pharmacology.

[23]  E. Peel,et al.  Etoposide--an effective single drug for treating bronchogenic carcinoma. , 1982, Clinical oncology.

[24]  M. Tempero,et al.  VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy. , 1981, Cancer clinical trials.

[25]  A. Goldhirsch,et al.  Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer. , 1981, Medical and pediatric oncology.

[26]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[27]  J. A. Mabel.  Therapeutic synergism in murine tumors for combinations of cis-diaminedichloroplatinum with vp 16-213 or bcnu. Abstr. , 1979 .